Unlocking the secrets of cancer stem cells: Immune checkpoint inhibitors face their formidable foes
- PMID: 37267909
- DOI: 10.1016/j.stem.2023.05.011
Unlocking the secrets of cancer stem cells: Immune checkpoint inhibitors face their formidable foes
Abstract
In this issue of Cell Stem Cell, Beziaud et al.1 show that immunotherapy induces stem-like properties in models of breast cancer. Strikingly, T-cell-derived IFNγ promotes cancer stem cell (CSC) phenotypes, therapy resistance, and metastasis. Targeting BCAT1 downstream offers promise for enhancing immunotherapy outcomes.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The author declares no competing interests.
Comment on
-
IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy.Cell Stem Cell. 2023 Jun 1;30(6):818-831.e6. doi: 10.1016/j.stem.2023.05.007. Cell Stem Cell. 2023. PMID: 37267916
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical